Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H18N2O |
| Molecular Weight | 278.3483 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | Meso |
SHOW SMILES / InChI
SMILES
O[C@@H]1C[C@@H]2CC[C@H](C1)N2C3=CC=C(C#N)C4=C3C=CC=C4
InChI
InChIKey=ATKWLNSCJYLXPF-FICVDOATSA-N
InChI=1S/C18H18N2O/c19-11-12-5-8-18(17-4-2-1-3-16(12)17)20-13-6-7-14(20)10-15(21)9-13/h1-5,8,13-15,21H,6-7,9-10H2/t13-,14+,15+
| Molecular Formula | C18H18N2O |
| Molecular Weight | 278.3483 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:14:54 GMT 2023
by
admin
on
Sat Dec 16 09:14:54 GMT 2023
|
| Record UNII |
U8VS41J5O6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-AC-262536
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U8VS41J5O6
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY | |||
|
870888-46-3
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY | |||
|
DTXSID701336168
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY | |||
|
44512434
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY | |||
|
AC-262,536
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY | AC-262,356 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator. Chemically it possesses endo-exo isomerism, with the endo form being the active form. It acts as a partial agonist for the androgen receptor with a Ki of 5nM, and no significant affinity for any other receptors tested. In animal studies it produced a maximal effect of around 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen. | ||
|
DB13935
Created by
admin on Sat Dec 16 09:14:54 GMT 2023 , Edited by admin on Sat Dec 16 09:14:54 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
